Sarepta Therapeutics (SRPT) Gross Margin (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,284.00 |
| Dec 31, 2025 | -5,226.00 |
| Sep 30, 2025 | -1,279.00 |
| Jun 30, 2025 | 7,821.00 |
| Mar 31, 2025 | -8,308.00 |
| Dec 31, 2024 | -47.00 |
| Sep 30, 2024 | -735.00 |
| Jun 30, 2024 | -5.00 |
| Mar 31, 2024 | -270.00 |
| Dec 31, 2023 | 163.00 |
| Sep 30, 2023 | 14,221.00 |
| Jun 30, 2023 | -13,955.00 |
| Mar 31, 2023 | 439.00 |
| Dec 31, 2022 | 102.00 |
| Sep 30, 2022 | -133.00 |
| Jun 30, 2022 | 12,499.00 |
| Mar 31, 2022 | -11,454.00 |
| Dec 31, 2021 | -1,597.00 |
| Sep 30, 2021 | 138.00 |
| Jun 30, 2021 | 145.00 |
| Mar 31, 2021 | 8,439.00 |
| Dec 31, 2020 | -3,285.00 |
| Sep 30, 2020 | -1,547.00 |
| Jun 30, 2020 | 4,416.00 |
| Mar 31, 2020 | -7,988.00 |
| Dec 31, 2019 | -239.00 |
| Sep 30, 2019 | 365.00 |
| Jun 30, 2019 | -295.00 |
| Mar 31, 2019 | 170.00 |
| Dec 31, 2018 | -442.00 |
| Sep 30, 2018 | -198.00 |
| Jun 30, 2018 | -52.00 |
| Mar 31, 2018 | -245.00 |
| Dec 31, 2017 | 51.00 |
| Sep 30, 2017 | -526.00 |
| Jun 30, 2017 | -7.00 |